Correlation Between Harpoon Therapeutics and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Harpoon Therapeutics and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harpoon Therapeutics and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Harpoon Therapeutics and Passage Bio, you can compare the effects of market volatilities on Harpoon Therapeutics and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harpoon Therapeutics with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harpoon Therapeutics and Passage Bio.
Diversification Opportunities for Harpoon Therapeutics and Passage Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Harpoon and Passage is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Harpoon Therapeutics and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Harpoon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harpoon Therapeutics are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Harpoon Therapeutics i.e., Harpoon Therapeutics and Passage Bio go up and down completely randomly.
Pair Corralation between Harpoon Therapeutics and Passage Bio
If you would invest (100.00) in Harpoon Therapeutics on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Harpoon Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Harpoon Therapeutics vs. Passage Bio
Performance |
Timeline |
Harpoon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Passage Bio |
Harpoon Therapeutics and Passage Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Harpoon Therapeutics and Passage Bio
The main advantage of trading using opposite Harpoon Therapeutics and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harpoon Therapeutics position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.Harpoon Therapeutics vs. Passage Bio | Harpoon Therapeutics vs. Black Diamond Therapeutics | Harpoon Therapeutics vs. Alector | Harpoon Therapeutics vs. Stoke Therapeutics |
Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |